Lpath, Inc. to Present at the 2009 BIOCOM Investor Conference
10/23/2009 9:56:51 AM
More...
|
Lpath, Inc. Receives Grants From the National Institutes of Health (NIH) and Publishes Key Paper in the Proceedings of the National Academy of Sciences
10/20/2009 10:54:14 AM
More...
|
Lpath, Inc.'s iSONEP Is Well Tolerated at All Dose Levels in a Phase 1 Trial in Wet-AMD Patients
10/8/2009 10:09:17 AM
More...
|
Lpath, Inc. and Merck Serono Extend ASONEP(TM) Collaboration
9/24/2009 1:36:59 PM
More...
|
Lpath, Inc. Achieves Merck Serono Milestone
8/24/2009 10:46:30 AM
More...
|
Lpath, Inc. Completes Enrollment of Patients in iSONEP(TM) Phase 1 Clinical Trial
8/18/2009 10:44:02 AM
More...
|
Lpath, Inc. to Present at the Southern California Investor Conference
8/14/2009 9:58:51 AM
More...
|
Lpath, Inc. Receives $3 Million Grant From the National Cancer Institute
6/4/2009 11:10:55 AM
More...
|
Lpath, Inc. to Provide First Quarter 2009 Business Review and Clinical Update Conference Call on Thursday, June 4 at 4:30 p.m. ET
6/1/2009 11:09:31 AM
More...
|
Lpath, Inc.'s Scientists and Collaborators Present Favorable New Study Data of Leading Cancer Drug Candidate, ASONEP(TM)
4/21/2009 11:50:26 AM
More...
|
|